100 related articles for article (PubMed ID: 22617189)
21. [Effects of anti-arrhythmics on the sinus rhythm. Evaluation using long-term electrocardiographic recordings quantified by the Atrec system].
Leclercq JF; Rosengarten MD; Attuel P; Kural S; Milosevic D; Coumel P
Arch Mal Coeur Vaiss; 1980 Aug; 73(8):903-11. PubMed ID: 6106463
[No Abstract] [Full Text] [Related]
22. Highlights in clinical autonomic neurosciences: treatment insights for postural tachycardia syndrome and inappropriate sinus tachycardia.
Raj SR
Auton Neurosci; 2013 Oct; 177(2):72-3. PubMed ID: 23830785
[No Abstract] [Full Text] [Related]
23. [The use of metoprolol tartrate during restoration of sinus rhythm and its subsequent maintenance in patients with chronic atrial fibrillation].
Solov'ev OV; Efremov DN; Onuchina EL; Solov'eva NV; Kononov SV
Kardiologiia; 2009; 49(5):26-9. PubMed ID: 19463131
[No Abstract] [Full Text] [Related]
24. [Local propranolol blocking of the beta-adrenergic receptors of the sinoatrial node during intravenous infusion of isoproterenol. Experimental research].
Mezzacapo B; Massaria E; Di Fabio D
Minerva Cardioangiol; 1969 Dec; 17(12):1074-9. PubMed ID: 4392066
[No Abstract] [Full Text] [Related]
25. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
[TBL] [Abstract][Full Text] [Related]
26. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
Hidalgo FJ; Anguita M; Castillo JC; Rodríguez S; Pardo L; Durán E; Sánchez JJ; Ferreiro C; Pan M; Mesa D; Delgado M; Ruiz M
Int J Cardiol; 2016 Aug; 217():7-11. PubMed ID: 27167103
[TBL] [Abstract][Full Text] [Related]
27. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
[TBL] [Abstract][Full Text] [Related]
28. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
[TBL] [Abstract][Full Text] [Related]
29. Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine.
Mehta N; Bapat A; Tedrow U; Stevenson WG; Koplan B
Europace; 2017 Jul; 19(7):1100. PubMed ID: 28431002
[No Abstract] [Full Text] [Related]
30. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
[TBL] [Abstract][Full Text] [Related]
31. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
32. Heart rate reduction is probably not the main beneficial mechanism by which beta blockade improves outcome in patients with systolic chronic heart failure.
Fragasso G; Salerno A; Margonato A
Am J Cardiol; 2008 Aug; 102(4):506-7. PubMed ID: 18678315
[No Abstract] [Full Text] [Related]
33. BEAUTIFUL results--the slower, the better?
Reil JC; Böhm M
Lancet; 2008 Sep; 372(9641):779-80. PubMed ID: 18757092
[No Abstract] [Full Text] [Related]
34. Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
Böhm M; Borer JS; Camm J; Ford I; Lloyd SM; Komajda M; Tavazzi L; Talajic M; Lainscak M; Reil JC; Ukena C; Swedberg K
Eur J Heart Fail; 2015 May; 17(5):518-26. PubMed ID: 25801408
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction.
Sette A; Martino A; Lioy E; Calò L
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):815-7. PubMed ID: 20233274
[TBL] [Abstract][Full Text] [Related]
36. [Structure of the sinus dysfunction in hypertensive patients].
Tuev AV; Poteshkina NG; Grigoriadi NE
Ter Arkh; 2004; 76(8):36-8. PubMed ID: 15471394
[No Abstract] [Full Text] [Related]
37. The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure.
Ozturk S; Öztürk S; Erdem FH; Erdem A; Ayhan S; Dönmez İ; Yazıcı M
J Interv Card Electrophysiol; 2016 Sep; 46(3):253-8. PubMed ID: 27039084
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacological control of heart rate].
Sirtori CR; Franceschini G
Ann Ital Med Int; 1994 Oct; 9 Suppl():29S-35S. PubMed ID: 7857754
[TBL] [Abstract][Full Text] [Related]
39. The secondary poststimulative phase after rapid atrial pacing: its importance in the diagnosis of sinus node dysfunction.
Szatmáry L; Veress G; Borbola J; Elkafarna A; Zorándy A; Czapko M
Acta Med Acad Sci Hung; 1981; 38(2):97-107. PubMed ID: 6119867
[TBL] [Abstract][Full Text] [Related]
40. Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure.
De Ferrari GM; Mazzuero A; Agnesina L; Bertoletti A; Lettino M; Campana C; Schwartz PJ; Tavazzi L
Eur J Heart Fail; 2008 Jun; 10(6):550-5. PubMed ID: 18486549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
